Paratek Pharmaceuticals, INC.

Biopharmaceutical company.

Based in PA

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $40K in lobbying spend across 5 quarterly filings, Paratek Pharmaceuticals, INC is an active lobbying client. Their lobbying covers 2 issue areas.

$40K
Total Spend
1
Years Active
1
Firms Hired
3
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2023$40K

Issues Lobbied

MEDBudget/Appropriations

Lobbying Firms

The Conafay Group, LLC

Lobbyists

Stephen ConafayDarin GardnerBryan Shuy

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: MED, Budget/Appropriations

  • •Support for medical/disease research and advocacy.
  • •Procurement of novel antibiotic.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?

Related Investigations

The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Similar Clients

University of Pennsylvania Perelman School of Medicine
$1.0M total spend
Ecri Institute
$230K total spend
Association for Frontotemporal Degeneration
$180K total spend
Calgon Carbon Corporation
$139K total spend
Moberg Analytics, INC.
$120K total spend

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis🏛️ Agency Pressure

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.